12-25552902-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145728.2(LMNTD1):c.58G>A(p.Glu20Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000111 in 1,552,412 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145728.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMNTD1 | NM_001145728.2 | c.58G>A | p.Glu20Lys | missense_variant | 2/10 | ENST00000458174.7 | NP_001139200.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNTD1 | ENST00000458174.7 | c.58G>A | p.Glu20Lys | missense_variant | 2/10 | 2 | NM_001145728.2 | ENSP00000407353 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000559 AC: 85AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000169 AC: 27AN: 159924Hom.: 0 AF XY: 0.000131 AC XY: 11AN XY: 83952
GnomAD4 exome AF: 0.0000614 AC: 86AN: 1400102Hom.: 1 Cov.: 30 AF XY: 0.0000521 AC XY: 36AN XY: 690964
GnomAD4 genome AF: 0.000565 AC: 86AN: 152310Hom.: 0 Cov.: 32 AF XY: 0.000510 AC XY: 38AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2024 | The c.58G>A (p.E20K) alteration is located in exon 2 (coding exon 1) of the LMNTD1 gene. This alteration results from a G to A substitution at nucleotide position 58, causing the glutamic acid (E) at amino acid position 20 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at